The EuLV system: lentiviral vector production based on stable producer cell lines

Cell & Gene Therapy Insights 2021; 7(3), 387

10.18609/cgti.2021.063

Published: 21 April 2021
FastFacts
Roy Bin Liu

Watch the video or read the poster to learn:

  • Why does consistent, large-scale vector production remain a challenge?
  • How can stable producer lines help meet rising demand as we enter the era of gene therapy?

About the speaker

Roy Bin Liu Business Development Director, EurekaBio. Mr Liu graduated from the Hong Kong University of Science and Technology with a Masters degree in Biotechnology. He previously worked in Bio-techne and InvivoGen. Mr Liu joined Eureka Bio in 2016, and has extensive knowledge of the cell and gene therapy industry, and is experienced in business development, project management, process development, cGMP etc.